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After nerve injury some primary afferent neurones,
particularly nociceptors, develop a novel excitatory response
to sympathetic efferent activity or exogenously applied
adrenergic agonists (Sato & Perl, 1991; Bossut & Perl, 1995;
O’Halloran & Perl, 1997; Abdulla & Smith, 1997). Similarly,
afferent fibres terminating in a neuroma formed after
transection of a peripheral nerve become responsive to
adrenergic agents (Wall & Gutnick, 1974). A partial loss of
sympathetic innervation also induces an adrenergically
produced excitation of cutaneous nociceptors (Bossut et al.
1996). The sympathetic adrenergic excitation takes place at
the peripheral terminals of nociceptors or the cell body of
dorsal root ganglion (DRG) neurones and is reversibly blocked
by áµ-adrenergic antagonists. Excitation of nociceptors by
adrenergic agents and sympathetic stimuli has also been
reported to be associated with inflammation (Hu & Zhu,
1989; Sato et al. 1993). It is possible that denervation and
inflammation serve as stimuli for alterations in expression of
adrenergic receptors by DRG neurones. Increased catechol-
aminergic innervation of DRG after peripheral nerve injury
(McLachlan et al. 1993) also is possibly related to altered
expression of adrenergic receptors.
Causalgia and related dystrophies are syndromes in which
injury to regional innervation leads to a spontaneous burning
pain accompanied by allodynia (pain resulting from non-
noxious stimuli) and hyperalgesia in a partially denervated
area (Nathan, 1947; Janig, 1992). These symptoms are often
relieved or modified, at least temporarily, by sympathectomy
(see review by Gybels & Sweet, 1989). Several proposals have
been put forth to explain the relationship of the sympathetic
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1. Immunocytochemistry with polyclonal antibodies directed against specific fragments of
intracellular loops of á2A- and á2C-adrenergic receptors (á2A-AR, á2C-AR) was used to
explore the possibility that expression of these receptors in dorsal root ganglion (DRG)
neurones of rat alters as a result of peripheral nerve injury or localized inflammation.
2. Small numbers of neurones with positive á2A-AR immunoreactivity (á2A-AR-IR) were
detected in DRG from normal animals or contralateral to nerve lesions. In contrast, after
complete or partial sciatic nerve transection the numbers of ipsilateral LÚ and LÛ DRG somata
expressing á2A-AR-IR sharply increased (>5-fold). There was no discernible change in the
number of DRG neurones exhibiting á2A-AR-IR innervating a region in association with
localized chemically induced inflammation.
3. After nerve injury, double labelling with Fluoro-Gold, a marker of retrograde transport from
transected fibres, or by immunoreactivity for c-jun protein, an indicator of injury and
regeneration, suggested that many of the neurones expressing á2A-AR-IR were uninjured by
the sciatic lesions.
4. In general the largest proportionate increase in numbers of neurones labelled by á2A-AR-IR
after nerve lesions appeared in the medium—large diameter range (31—40 ìm), a group
principally composed of cell bodies of low threshold mechanoreceptors. The number of small
diameter DRG neurones labelled by á2A-AR-IR, a category likely to include somata of
nociceptors, also increased but proportionately less.
5. Relatively few DRG neurones exhibited á2C-AR-IR; this population did not appear to
change after either nerve lesions or inflammation.
6. These observations are considered in relation to effects of nerve injury on excitation of
primary afferent neurones by sympathetic activity or adrenergic agents, sympathetically
related neuropathy and reports of sprouting of sympathetic fibres in DRG.
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system to pain after nerve injury or denervation, including
the possibility that primary afferent neurones develop novel
adrenergic receptors (Nathan, 1947; Devor & Janig, 1981;
Sato & Perl, 1991; Perl, 1994).
Two áµ-adrenergic receptor subtypes (A and C) have wide
distribution in the central nervous system (Nicholas et al.
1993; Scheinin et al. 1994; Rosin et al. 1996; Talley et al.
1996; Gold et al. 1997). Our experiments were directed at
determining whether the number and spectrum of primary
afferent neurones expressing these adrenergic receptors alters
as a consequence of either injury to a mixed somatosensory
nerve or an artificially induced inflammation. These
observations have been reported in a preliminary fashion
(Birder & Perl, 1996).
METHODS
A total of 42 adult Wistar rats (150—250 g) of both sexes were
used; eight served as unoperated controls. All procedures on living
rats were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of North Carolina, Chapel
Hill.
Peripheral nerve lesions
Twenty animals were deeply anaesthetized by a combination of
ketamine (10 mg kg¢ i.p.) and xylazine (10 mg kg¢ i.p.).
Anaesthesia was established as being adequate for surgery by
periodically testing for the absence of a withdrawal reflex to a
strong pinch of a hindpaw and absence of an eye blink reflex to
contact with the cornea. Additional anaesthetic was given to
maintain the areflexic state until surgery was completed. Usual
surgical aseptic precautions were employed to expose the sciatic
nerve of one leg through an incision over the sciatic notch and to
either partially (n = 7) or totally (n = 13) transect it using fine
sharp scissors. The aim of the partial transection was to divide the
same one-half of the nerve each time; however, variability in exact
exposure and orientation of the sciatic nerve made it probable that
the partial lesions varied from animal to animal. In five animals,
after total transection of the sciatic nerve, the central cut end was
dipped into Fluoro-Gold (3% wÏv), a retrogradely transported
substance taken up by cutÏdamaged nerve fibres of all sizes
(Schmued & Fallon, 1986; Baranowski et al. 1992), to identify DRG
somata with transected peripheral fibres. Eighteen of the 20 animals
were studied 7—14 days after the sciatic lesions; the survival period
for two animals was 72 days. We made no systematic attempt to
test for hyperalgesia, although the lesioned animals’ behaviour was
unremarkable during their survival with no visible signs of distress
other than relatively minor favouring of the affected limb. The rare
animal exhibiting autotomy after complete sciatic transection was
killed immediately by an overdose of pentobarbital anaesthetic and
was not included in the analyses.
Induced inflammation
Twelve other animals anaesthetized with ketamine and xylazine to
areflexia had 0·1 ml of one of the following injected subcutaneously
into the plantar part of one hindpaw through a 30 gauge needle:
carrageenan (4 mg in 0·9% NaCl), formalin (4% in 0·9% NaCl) or
Freund’s complete adjuvant. These agents cause inflammation and
hyperalgesia, which, in some cases, can persist for up to 2 weeks
(Iadarola et al. 1988). After these injections the animals developed
localized oedema and guarded the affected limb; otherwise their
behaviour was unremarkable. Subcutaneous plantar injections of
0·1 ml of Fluoro-Gold (3% wÏv) were made in two additional
anaesthetized rats to identify DRG neurones with fibres
innervating the foot. Eight of this group of 14 animals, including
two injected with Fluoro-Gold, survived for 1—5 days; the
remaining six were killed 2 weeks after the plantar injections.
Immunohistochemistry
Terminally, the animals were deeply anaesthetized to areflexia
with the ketamine—xylazine mixture and killed by intracardiac
perfusion with ice-cold 0·9% NaCl followed by a zinc formalin
fixative (Anatech, Inc., Battle Creek, MI, USA), a solution of
formaldehyde and zinc sulphate used at a working concentration of
4% formaldehyde. Good perfusion fixation proved essential for
consistent immunocytochemical staining and low background. The
DRGs contributing to the innervated region were removed,
postfixed for 1—2 h in the zinc formalin fixative and then
cryoprotected in 25% sucrose. Serial frozen (10 ìm) sections were
mounted on slides (superfrost). Non-specific binding was blocked by
3% normal goat serum.
The primary polyclonal antibody against the presumed rat á2A-
adrenergic receptor (á2A-AR) was developed by immunizing
rabbits with a recombinant fusion protein prepared from the cloned
rat gene; the protein consisted of glutathione-S-transferase (GST)
and a 47 amino acid fragment from the third intracellular loop
(Rosin et al. 1993). The targeted fragment of the receptor differed
substantially from equivalent regions of other á2-AR subtypes.
Receptor selectivity of the affinity purified antisera was established
by Western blot analysis of COS cells (a transformed fibroblast-like
cell line derived from African green monkey kidney) expressing
only the á2A receptor subtype. It was established that this á2A-AR
antibody lacked cross-reactivity with other áµ-receptor subtypes
and recognized native receptor as well as receptor in fixed tissue
(Rosin et al. 1993). The polyclonal antibody against the á2C-AR was
similarly produced using a recombinant fusion protein consisting of
GST and a 70 amino acid fragment of the 3rd intracellular loop and
characterized in the same fashion (Rosin et al. 1996).
DRG sections were first incubated with affinity purified á2A-AR
or á2C-AR antibodies (2·5 ìg ml¢ for 48 h) which had been
preabsorbed for 2—3 h with a 5- to 10-fold excess (wÏw) of GST
(Rosin et al. 1993) and then, after rinsing, with a cyanine fluorescent
probe (cy-2 or cy-3 conjugated anti-rabbit IgG).
The c-jun marker for DRG neuronal injury (Jenkins et al. 1993) was
compared with áµ-AR labelling using a cocktail for the initial
incubation containing both the á2A-AR primary antibody and a
c_jun antibody (mouse monoclonal). After rinsing, these sections
were further incubated in a second cocktail containing cyanine
fluorescent probes (cy-2 conjugated anti-rabbit IgG, cy-3 conjugated
anti-mouse IgG).
Data analysis
The processed DRG sections were examined by epifluorescence and
transmitted light microscopy; images were captured using a high
resolution video camera (Optronics DE1-470T) and an MS DOS
computer fitted with an image analysis program (Image-Pro Plus, v.
2.0 or 3.0, Media Cybernetics, Silver Spring, MD, USA). The
diameter of labelled neurones was determined by the imaging
program from a tracing of the perimeter of each counted profile
containing a nucleus to give a mean diameter for each cell. The
number of labelled neurones in a ganglion was estimated from
counts at moderate to high magnification (²250—630) of positively
stained profiles containing nuclei in 10 sequential sections separated
by 100 ìm. All neurones in each counted section were examined.
All cell counts (either á2A-AR-IR or á2C-AR-IR) are presented as
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the mean number of positive neurones per 10 sections ± standard
deviation (s.d.) from each ganglion. For the size distributions shown
in Fig. 7, the values reported are the percentage of á2A- or á2C-AR-
IR neurones counted. Student’s t test was used to estimate the
probability that differences between means of the experimental
groups could have occurred by chance.
Materials
Chemicals were obtained as follows: Fluoro-Gold from Fluorochrome,
Inc., Eaglewood, CO, USA; cyanine conjugated anti-rabbit IgG
from Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA, USA or Rockland, Inc., Gilbertsville, PA, USA; normal goat
serum from Vector Laboratories, Inc., Burlingame, CA, USA. Other
chemical compounds were obtained from Sigma. Slides (superfrost)
used to mount the tissue sections were obtained from Fisher
Scientific, Pittsburgh, PA, USA.
RESULTS
á2A-IR and á2C-IR expression after partial sciatic
nerve lesions
Examples of the á2A-IR-like reaction product in DRG
neurones are shown in Fig. 1A and C. As described by Rosin
et al. (1993), the punctate bodies varied in both size and
number (mean 12, range 8—16, for each positive neuronal
profile) and often circled the soma. The á2C reaction product
differed; it appeared as a more typical diffuse label
distributed throughout the cytoplasm (Fig. 1E). Neither the
punctate stained bodies nor the diffuse label was present
when the primary antibodies were preabsorbed with the
respective á2A or á2C fusion protein (5- to 10-fold excess;
Fig. 1B, D and F) or if the primary antisera were omitted.
As Table 1 and Figs 2 and 3 indicate, in unoperated animals
few DRG neurones (< 25 neurones per 10 sections) exhibited
either á2A or á2C immunoreactivity (IR). Seven to 14 days
after either partial or complete transection of the sciatic
nerve, the number of neurones in the ipsilateral LÚ and LÛ
DRG exhibiting á2A-AR-IR was sharply increased. Most of
the observations were from animals surviving 14 days after
the sciatic lesion; however, there was considerable variation
between animals at all time points. No significant differences
were detected between animals killed at 7 days and those
surviving up to 14 days. Therefore, data were pooled for the
animals studied 7—14 days after the sciatic transections.
Figure 4A and B and Table 1 show that after a partial
transection of the sciatic nerve (n = 7) significantly more
(>6-fold, P < 0·05) ipsilateral LÚ and LÛ DRG neurones
demonstrated á2A-AR-IR than in normal or equivalent
contralateral ganglia. Complete transection of the sciatic
nerve resulted in similar marked increases in the number of
neurones demonstrating á2A-positive IR in LÚ and LÛ
ganglia of the lesioned side relative to normal ganglia
(Fig. 5A and B and Table 1). Some ganglia contralateral to
the sciatic lesions had apparent small increases in numbers
of á2A-AR-IR neurones (Table 1) compared with normal
animals but the variation from animal to animal was large
enough for these differences to have occurred by chance
(P > 0·05). To estimate the proportion of neurones in a
ganglion expressing á2A-AR-IR, 500 LÚ neurones were
counted in 10 sections spaced by 100 ìm. After a partial
sciatic transection, 14·8% of this count exhibited á2A-AR-
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Table 1. Average number of ipsilateral or contralateral neurones in DRG expressing á2A-AR (LÚ, LÛ)
or á2C-AR (LÚ only) in unoperated animals and animals with partial or complete sciatic transection
or inflammation
––––––––––––––––––––––––––––––––––––––––––––––
Normal Partial Complete Inflammation
––––––––––––––––––––––––––––––––––––––––––––––
á2A-like-IR
Ipsilateral LÚ 19·2 ± 5·8 135·2 ± 46·5 194·3 ± 57·3 12·8 ± 3·4
Contralateral LÚ 20·3 ± 5·7 21·4 ± 8·7 27·7 ± 9·4 16·1 ± 7·4
á2A-like-IR
Ipsilateral LÛ 16·3 ± 1·0 238·3 ± 65·1 125·5 ± 52·3 –
Contralateral LÛ 15·2 ± 1·1 34·4 ± 14·7 21·4 ± 9·2 –
á2C-like-IR
Ipsilateral LÚ 17·4 ± 5·4 13·6 ± 5·7 16·2 ± 7·6 17·2 ± 5·1
Contralateral LÚ 17·1 ± 5·2 11·8 ± 3·2 18·4 ± 5·4 19·5 ± 5·4
––––––––––––––––––––––––––––––––––––––––––––––
Normal, unoperated animals (n = 8); Partial, 7—14 days after partial sciatic transection (n = 7); Complete,
complete sciatic transection (n = 11); Inflammation, 1—14 days after injection of Freund’s adjuvant
(n = 4). Data are means ± s.d. The range of the number of positive cells in 10 sections in different animals
was as follows. á2A-AR-IR normal: ipsilateral (IL), LÚ, 12·8—27·1; contralateral (CL), LÚ, 11·4—24·7; IL, LÛ,
14·5—17·5; CL, LÛ, 14·0—16·5. Partial sciatic transection: IL, LÚ, 82·1—184·2; CL, LÚ, 12·2—32·3; IL, LÛ,
118·5—315·0; CL, LÛ, 20·1—61·2. Complete sciatic transection: IL, LÚ, 71·5—257·0; CL, LÚ, 8·8—35·4; IL,
LÛ, 31·2—195·6; CL, LÛ, 10·2—35·6. Inflammation: IL, LÚ, 8·7—17·4; CL, LÚ, 8·1—26·8. For á2C-AR-IR, as
follows. Normal: IL, LÚ, 11·8—23·2; CL, LÚ, 12·5—24·1. Partial sciatic transection: IL, LÚ, 4·2—20·5; CL,
LÚ, 3·5—25·3. Complete sciatic transection: IL, LÚ, 8·5—28·2; CL, LÚ, 9·2—29·1. Inflammation: IL, LÚ,
10·3—22·4; CL, LÚ, 10·7—25·2.
––––––––––––––––––––––––––––––––––––––––––––––
IR. After complete sciatic transection in another animal, a
somewhat larger proportion, 21·1% of 500 neurones,
showed á2A-AR-IR. Considerable variation occurred from
animal to animal as is documented by the range of values in
the legend to Table 1, although even the smallest number
of labelled neurones in the experimental group was
substantially greater than was found in normal ganglia. Few
á2A-labelled neurones (<20 neurones per 10 sections) were
found in adjacent segments (L1—L×, LÜ) after sciatic lesions.
Seventy-two days after complete sciatic nerve transection
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Figure 1. Epifluorescence image of sections from LÚ dorsal root ganglia depicting áµ-AR-IR
A and C, sections depicting á2A-AR-IR after partial sciatic nerve transection (A) and complete sciatic nerve
transection (C). B and D, adjacent sections to A and C showing block of reaction product by addition of
á2A_AR fusion protein. Arrows indicate positive reaction product. E, epifluorescence image of a section from
LÚ dorsal root ganglion depicting á2C-AR-IR (complete sciatic transection 14 days previously). Identical images
were found in DRG of normal animals. F, block of reaction in a section adjacent to E by addition of á2C-AR
fusion protein. Arrow indicates neurone with positive reaction product. Calibration bar, 10 ìm for each panel.
(n = 2), the number of á2A-AR-IR neurones in ipsilateral LÚ
and LÛ DRG did not significantly differ from findings in
unoperated controls (<20 cells per 10 sections, P > 0·05).
In contrast to the á2A observations, after partial or complete
sciatic transection no increase appeared in the number of
ipsilateral neurones labelled by á2C-AR-IR (Fig. 3 and
Table 1).
Only limited and scattered á2A-AR-IR appeared in the
control spinal dorsal horn. No obvious increase in á2A-AR-
IR was noted with the antibody used in the ipsilateral
LÚÏLÛ spinal dorsal horn after nerve injury. Spinal cord
á2C_AR-IR also did not increase after either complete or
partial sciatic transections.
After the sciatic nerve lesions, all diameter ranges of
ipsilateral LÚ DRG neurones expressing á2A-ARs increased
in number, although the largest proportionate increase
usually occurred in the medium—large diameter category
(31—40 ìm). After partial transection, 41·5% of labelled LÚ
neurones were in the 31—40 ìm category, with a mean
diameter of 34 ìm. Following complete sciatic transection
40·3% of the labelled LÚ cells were in the 31—40 ìm range
(mean diameter of 36 ìm). This distribution contrasts with
the diameter spectra of neuronal somata of comparable DRG
from normal rat in which notably smaller cells predominate
(Harper & Lawson, 1985; Tandrup, 1993). On the other hand,
in mean values from LÛ ganglia after partial lesions, the
greatest number of á2A-AR-IR appeared in the 21—30 ìm
group, although the size distribution of labelled neurones
remained skewed toward the larger diameters relative to
that of the DRG population as a whole (Fig. 4). Counting
only neurones in histological sections with nuclei theoretically
creates a bias in favour of large neurones (Harper & Lawson,
1985; Tandrup, 1993); however, this shift should account
for only a small part of these distributions.
á2A-AR-IR and evidence of injury
An indication of which DRG neurones in the LÚÏLÛ
ganglia had divided peripheral fibres after complete sciatic
transections was gained from experiments with Fluoro-Gold
(FG). Seven to 14 days after complete sciatic nerve
transection, the number of DRG neurones that were labelled
by both á2A-AR-IR and FG (72 neurones per 10 sections)
was significantly greater (P < 0·05) than the number of
á2A_AR-IR-positive cells in control or contralateral ganglia
(Fig. 6A); however, more neurones showed only á2A-AR-IR
than those that were double-labelled (P < 0·05, Fig. 6A).
About 25% of FG-containing neurones were á2A-AR-IR
positive. For both FG-positive and FG-negative subsets most
of the á2A-AR-IR-positive neurones were of the medium—
large diameter category (31—40 ìm).
Transection of a peripheral nerve results in a massive
increase in the number of DRG neurones expressing the c_jun
proto-oncogene from the very low level present in the
absence of injury (Jenkins & Hunt, 1991). The c-jun
expression may be due to alterations in growth or neuro-
tropic factors (Jenkins et al. 1993). The increase in c_jun
labelling continues until regeneration of the nerve is complete
(Herdegen et al. 1993). We used immunoreactivity to detect
the presence of c-jun protein and thereby to identify
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Figure 3. Number of LÚ DRG neurones expressing á2C-AR-
IR in unoperated animals (n = 8) or after partial (n = 7) or
complete transection (n = 11) of the sciatic nerve
Data are shown as means per 10 sections ± s.d.No change of
á2C_AR expression was noted after injection of identical
inflammatory agents as in Fig. 2.
Figure 2. Number of LÚ DRG neurones expressing á2A
AR-IR in 8 unoperated animals (Control) or after injection into
the ipsilateral hindpaw of the inflammatory agents Freund’s
complete adjuvant (n = 4), carrageenan (Carrag., n = 4) and
formalin (n = 4). Data are means per 10 sections ± s.d.
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Figure 5. Diameter distribution of DRG neurones expressing
á2A_AR-IR after complete transection of the sciatic nerve 7—14 days
previously
Data are means per 10 sections ± s.d. (n = 11 animals). Filled bars,
ipsilateral to the lesion; hatched bars, contralateral. A, LÚ DRG; B, LÛ DRG.
Figure 6. Diameter distribution of DRG neurones expressing
á2A_AR-IR in relation to markers for transection or injury of
peripheral fibres
A,mean number (± s.d.) of á2A-AR-IR neurones in 10 sections of the
ipsilateral LÚ DRG from 5 animals after complete sciatic nerve transection
7—14 days previously. Filled bars, á2A-AR-IR only; hatched bars, á2A-AR-
IR and retrogradely transported Fluoro-Gold (FG). B, mean number (± s.d.)
of á2A-AR-IR neurones in 10 sections of the ipsilateral LÚ DRG from 6
animals after partial transection of the ipsilateral sciatic nerve. Filled bars,
á2A-AR-IR only; hatched bars, á2A-AR-IR and c-jun-IR. See Methods and
Results for additional details.
Figure 4. Diameter distribution of DRG neurones expressing
á2A_AR-IR after partial transection of the sciatic nerve 7—14 days
previously
Data are means per 10 sections ± s.d. (n = 7). Filled bars, ipsilateral to
lesion; hatched bars, contralateral to lesion. A, LÚ DRG; B, LÛ DRG. See
Methods for additional details.
neurones with peripheral fibres putatively transected or
otherwise injured by the nerve lesion. The proportion of
neurones in an LÚ DRG exhibiting c-jun-IR after the
complete sciatic nerve transections (36%) was roughly
comparable to those marked by FG in similar experiments
(28%; difference P > 0·05). The number of neurones in the
ipsilateral LÚ DRG expressing the á2A-AR-IR alone or in
combination with c-jun-IR increased significantly relative to
the contralateral side (P < 0·05); however, as with the FG
marker, the profiles with only á2A-AR-IR (presumably
uninjured) were more numerous (Fig. 6B). As depicted in
Fig. 7, after partial or complete sciatic transection, the c-jun
protein appeared in more small diameter than large diameter
DRG neurones (44% in the smallest diameter category,
10—20 ìm), as might be anticipated from the relative
proportion of small neurones in DRG. The distribution of
injury marked cells in Fig. 7 contrasts with the size
distribution of the largest category staining with both labels
(e.g. Fig. 6), those of medium—large diameter (31—40 ìm).
Nonetheless, some smaller diameter neurones (21—30 ìm)
had both á2A-AR-IR and c-jun-IR. It is noteworthy that not
all FG or c-jun-labelled neurones showed á2A-AR-IR. While
there is no certainty that either the retrograde and the c-jun
tags label all and only injured neurones, the similarity of
results with the two techniques suggests that after sciatic
lesions more uninjured neurones than injured ones develop
á2A-AR-IR.
Effects of local inflammation
The three agents injected into the plantar footpad to induce
local inflammation — carrageenan, formalin and Freund’s
adjuvant — produced variable degrees of oedema and
guarding of the hindlimb. Formalin and Freund’s adjuvant
caused the most marked local reactions. After induction of
the local inflammation, the number of neurones labelled by
either the á2A or the á2C antibodies in the LÚÏLÛ ganglia did
not significantly differ from controls (P > 0·05) either
ipsilaterally or contralaterally to the injected paw (Table 1
and Fig. 2).
DISCUSSION
Following partial and complete transection of the sciatic
nerve, the antibody we used against the á2A adrenergic
receptor fragmant labels a sharply increased number of
DRG neurones. The increase is confined to ipsilateral
ganglia supplying large numbers of afferent fibres to the
injured nerve (LÚ—LÛ). The proportion of á2A-AR-IR
neurones in ipsilateral ganglia adjacent to LÚ and LÛ remains
comparable to that of control animals or contralateral
ganglia. On the other hand, we noted no increase in the
number of neurones expressing á2C-AR-IR after the sciatic
injuries, an indication that the á2A-AR-IR changes were
specific. Increases in á2A-AR-IR also did not appear in the
inflammatory models.
There are considerable data favouring the concept that
immunoreactivity to the antibody we employed marks an
á2A-type of adrenergic receptor. The antibody has been
extensively characterized in other studies and shown to
label selectively neurones established to express the á2A_type
of adrenergic receptor (Rosin et al. 1993; Talley et al. 1996).
This characterization includes in situ hybridization studies
demonstrating the presence of á2A_AR-like mRNA (Zeng &
Lynch, 1991; Nicholas et al. 1993). However, other immuno-
cytochemical studies analysing the presence of áµ-adrenergic
receptors in DRG neurones have reported varying results,
including some differing quantitatively from ours (e.g.
Roberts & Connick, 1997; Gold et al. 1997). We can only
speculate about the basis of these differences. In part, it
could reflect differences in experimental protocols (e.g. Gold
et al. 1997). These could represent different experimental
procedures, varying immunocytochemical methods, cross-
reactivity with other proteins andÏor problems in
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Figure 7. Diameter distribution of neurones displaying c-jun-IR
after nerve injury
Note that the ordinate is the proportion (percentage) of the total
counted in LÚ ganglia (± s.d.). A, 788 counted positive neurones from
2 animals following complete ipsilateral sciatic transection. B, 658
counted positive neurones from 2 animals after partial ipsilateral sciatic
transection.
interpretation due to high levels of background reactivity.
From their published illustration, the latter could contribute
to the larger number of á2A- and á2C-immunoreactive DRG
neurones reported by Gold et al. (1997). We took special
care to keep the background in our analyses very low. Our
judgements were based on the presence of the punctate
reaction product, at least partially distributed around profiles
containing a nucleus. These criteria made for ready
identification of positive labelling. In our experiments, the
appearance of the reaction product and á2A-AR-IR staining
of neurones was regularly blocked by preabsorbance with
the fusion protein or omission of the primary antibody.
Uninjured as well as injured neurones participate in the
increase in á2A-AR-IR, as evidenced by the absence of labels
for transectionÏinjury (presence of Fluoro-Gold and c_jun
expression). Admittedly, the completeness of marking of
injured neurones can be questioned. The FG marker was
used only for complete transection and in this situation, it has
been argued to label retrogradely most, if not all, neurones
whose fibres are transected (Baranowski et al. 1992).
Similarly, the c-jun protein or mRNA is reported to appear
in many, if not all, injured and regrowing neurones after
axotomy (Jenkins et al. 1993; Herdegren et al. 1993). While
it is possible that some neurones with injured fibres were
unmarked by either the FG or the c-jun technique, it is
notable that substantial numbers of neurones with
á2A_AR_IR but lacking the other marker appeared in both
variations of the double-labelling experiments. Moreover, the
distribution of sizes of neurones labelled for the c-jun protein
compares well with the established distribution of neuronal
size in normal ganglia but differs distinctly from the size
distribution of the DRG neurones exhibiting the á2A-IR
after the partial or complete transections (cf. Figs 4, 5, 6
and 7). Therefore, the conclusion that substantial numbers
of uninjured neurones develop increased á2A_immuno-
reactivity after nerve injury seems tenable.
The proportion of neurones in a DRG exhibiting the
increased á2A-AR-IR presence after sciatic transection is
considerable. We estimate it to be about 15% or more. That
many neurones changing phenotype after nerve injury have
the capability to produce significant changes in afferent
signalling and sensory function. It is important to note that
not every injured neurone exhibited á2A-AR-IR, implying a
form of selectivity in the process.
A particularly puzzling part of our data is that the number
of LÛ DRG neurones in seven animals showing the á2A-AR-
IR after partial sciatic lesions was greater than either the
mean for LÚ or LÛ after complete transection. It is possible
that this apparent anomaly is the result of the large
proportion of apparently uninjured neurones that develop
the immunoreactivity. Whatever combination of factors
links the lesion of the nerve to the change in adrenergic
receptor expression, the partial lesions in our sample may
have selected more of those triggering the change in the LÛ
distribution. A possibility is the relative proportion of
sympathetic efferent fibres divided by the lesion (Bossut et
al. 1996). Perhaps interuption of both sets of fibres, primary
sensory and sympathetic postganglionic, combines to
influence the increased á2A-AR-IR. In any case, the number
of peripheral fibres divided does not appear to be directly
related to the number of DRG neurones showing increased
appearance of á2A-AR-IR.
It is also unclear how the increase in adrenergic receptor
expression after nerve lesions relates to reports of
inflammation-induced appearance of adrenergic excitation
of nociceptive afferent units. The absence of an increase in
the number of DRG neurones exhibiting á2A-AR-IR (or
á2C_AR-IR) in association with inflammation emphasizes
differences in the factors mediating its actions and those of
nerve injury.
A number of functional changes take place in primary
afferent neurones after a peripheral nerve injury including
the appearance of abnormal spontaneous activity (Wall &
Gutnick, 1974; Devor et al. 1994) and adrenergic excitation
of nociceptors (Sato & Perl, 1991; Bossut & Perl, 1995;
O’Halloran & Perl, 1997). It seems reasonable to hypothesize
that the increased number of DRG somata expressing an
áµ_adrenergic receptor marker is related to the induction of
adrenergic excitation of these afferent neurones at their
peripheral terminals (Sato & Perl, 1991; O’Halloran & Perl,
1997; Abdulla & Smith, 1997). This latter is consistent with
the apparent peripheral origin of some symptoms in human
cases of sympathetically related neuralgias (Nathan, 1947;
Wallin et al. 1976; Torebjork et al. 1995). A moderate increase
was detected in the number of small diameter neurones with
á2A-AR-IR. This size range of somata is likely to be
associated with C fibre receptors and therefore with
nociceptors (Harper & Lawson, 1985). However, the greatest
increase in á2A-AR-IR appeared in the medium—large
diameter group of DRG neurones, a category primarily
related to myelinated fibre, low threshold mechanoreceptors
(Harper & Lawson, 1985). Some types of low threshold
mechanoreceptors, muscle spindles, cutaneous slowly
adapting type I and Pacinian corpuscles in the normal
animal manifest enhanced activity after sympathetic
stimulation (e.g. Hunt, 1960; Akoev, 1981; Roberts et al.
1985; Barasi & Lynn, 1986). Our observations suggest that
the number of the latter types of sensory neurones with the
potential for excitement by adrenergic agents markedly
increases after partial denervation and that this increase
takes place in both injured and uninjured neurones. The
cellular mechanisms by which activation of an áµ-adrenergic
receptor leads to excitation of a neurone is not well
understood. Abdulla &Smith (1997) have provided evidence
indicating that after sciatic transection, nor-adrenaline
acting through an áµ-adrenergic receptor suppresses N-type
Ca¥ channel current in dissociated DRG neurones and
possibly thereby reduces Ca¥-mediated K¤ conductances.
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The latter could be expected to increase excitability of
neurones. In their work noradrenaline actions were
particularly evident in the smaller DRG somata. The áµ-AR-
mediated effect was not found for DRG neurones
dissociated from normal animals.
The development of sympathetic adrenergic excitation of
nociceptors conceptually is readily linked to neuropathic
pain (Sato & Perl, 1991; O’Halloran & Perl, 1997). On the
other hand, a connection between a possible sympathetic
excitatory action on low threshold mechanoreceptors and
the symptom of pain requires a more involved explanation
(e.g. Roberts, 1986). At this stage, the relationship of the
increased á2A-AR presence to neuropathic states is a matter
of conjecture (Devor, 1983; Sato & Perl, 1991; Perl, 1994).
Removal or loss of the peripheral sympathetic innervation
has been reported to be associated with increased
adrenergic receptor binding by some DRG somata
(Nishiyama et al. 1993) as well as by cells in other tissues
(Davies et al. 1982). The present increased expression of
áµ_AR-IR corresponds in time (1—3 weeks) to expected
expression of adrenergic denervation supersensitivity
(Cannon & Rosenblueth, 1949). The suggestion has been
made that sympathetically associated neuropathies may be
related to mechanisms underlying sympathetic denervation
supersensitivity (Perl, 1994). In this concept the presence of
sympathetic innervation and mediators would suppress
expression of the áµ-adrenergic receptors by DRG neurones.
The augmented á2A-adrenergic receptor-like expression we
observed may be a factor in the increase reported in
adrenergic connections from sympathetic postganglionic
fibres to dorsal root ganglia after peripheral nerve injury
(McLachlan et al. 1993; Chung et al. 1996). The ingrowth of
fibres staining for sympathetic markers is described by
McLachlan et al. (1993) to surround medium and large DRG
neurones at a time (2—3 months) when our observations on
two animals showed the á2A-AR-IR no longer to be elevated.
Although there may be a causal relationship between these
two phenomena, the nature of that linkage and the
significance of the increased sympathetic innervation
remains unclear.
The large number of apparently uninjured neurones
developing the á2A-receptor expression suggests a possible
basis could be alteration in the environment of DRG
neurones. The increased adrenergic receptor expression
conceivably could be triggered by processes related to growth
of transected fibres or expansion of the peripheral terminal
field (of uninjured fibres) following division of other
peripheral nerve fibres, afferent or sympathetic. Peripheral
nerve injury has been shown to result in a number of changes
in DRG neurones including induction of immediate-early
genes (e.g. c-jun) and trophic factors (Jenkins et al. 1993;
Zhou et al. 1996). It is possible that whatever factors (e.g.
leukemia inhibitory factor, Thompson & Majithia, 1998) and
processes stimulate DRG neurones with transected fibres to
respond with growth may spread to adjacent uninjured
neurones and cause them to undergo similar alterations.
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